These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients. Pietersma FL, van Dorp S, Minnema MC, Kuball J, Meijer E, Schuurman R, van Baarle D. Clin Infect Dis; 2011 Apr 01; 52(7):e144-8. PubMed ID: 21427386 [Abstract] [Full Text] [Related]
6. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Walker CM, van Burik JA, De For TE, Weisdorf DJ. Biol Blood Marrow Transplant; 2007 Sep 01; 13(9):1106-15. PubMed ID: 17697973 [Abstract] [Full Text] [Related]
7. Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection. Safdar A, Papadopoulous EB, Armstrong D. Bone Marrow Transplant; 2002 Jun 01; 29(11):913-6. PubMed ID: 12080357 [Abstract] [Full Text] [Related]
8. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan. Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S, Kasahara S, Iseki T, Yamaguchi T, Tojo A, Asano S. Eur J Haematol; 2008 Mar 01; 80(3):251-7. PubMed ID: 18081702 [Abstract] [Full Text] [Related]
16. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ. Cytometry B Clin Cytom; 2008 Jul 01; 74(4):211-20. PubMed ID: 18454493 [Abstract] [Full Text] [Related]
17. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. DesJardin JA, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR. Clin Infect Dis; 2001 Oct 15; 33(8):1358-62. PubMed ID: 11565077 [Abstract] [Full Text] [Related]
18. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E, Yuji K, Hori A, Shibata T, Masuoka K, Wake A, Miyakoshi S, Morinaga S, Taniguchi S. Transpl Infect Dis; 2007 Mar 15; 9(1):11-5. PubMed ID: 17313465 [Abstract] [Full Text] [Related]
19. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J, Meng XQ, Yang MF, Zhou L, Chen XM, Hu MJ, Fan WW, Ma WH, Li LJ. Hepatobiliary Pancreat Dis Int; 2006 Feb 15; 5(1):34-8. PubMed ID: 16481279 [Abstract] [Full Text] [Related]